Caricamento...
Monoclonal antibody as an emerging therapy for acute ischemic stroke
Acute ischemic stroke (AIS) is the 5(th) leading cause of death and the leading cause of neurological disability in the United States. The oxygen and glucose deprivation associated with AIS not only leads to neuronal cell death, but also increases the inflammatory response, therefore decreasing the...
Salvato in:
| Pubblicato in: | Int J Physiol Pathophysiol Pharmacol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
e-Century Publishing Corporation
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7486556/ https://ncbi.nlm.nih.gov/pubmed/32934765 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|